Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 246 M241 M245 M245 M258 M242 M 990 M Research & development —————— — Operating income 161 M163 M161 M172 M155 M210 M 698 M Non-Operating Income, Total 6 M6 M18 M5 M2 M18 M 43 M Interest expense, net of interest capitalized 28 M28 M23 M26 M22 M27 M 98 M Non-Operating Income, excl. Interest Expenses -28 M-28 M-23 M-26 M-22 M-27 M -98 M Unusual income/expense 6 M6 M18 M5 M2 M18 M 43 M Pretax income 187 M188 M204 M198 M188 M254 M 844 M Equity in earnings 13 M8 M12 M13 M5 M21 M 51 M Taxes 38 M36 M59 M39 M39 M46 M 183 M Non-controlling/minority interest —————— — After tax other income/expense -3 M-6 M-6 M-8 M-3 M-9 M -26 M Net income before discontinued operations 149 M152 M145 M159 M149 M208 M 661 M Discontinued operations —————— — Net income 149 M152 M145 M159 M149 M208 M 661 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 149 M152 M145 M159 M149 M208 M 661 M Basic earnings per share (Basic EPS) 3.793.863.694.053.795.27 16.8 Diluted earnings per share (Diluted EPS) 3.793.863.684.063.795.27 16.8 Average basic shares outstanding 39.3 M39.4 M39.3 M39.3 M39.3 M39.5 M — Diluted shares outstanding 39.3 M39.4 M39.4 M39.3 M39.3 M39.5 M — EBITDA 2.54 B2.87 B2.95 B3.21 B2.9 B3.21 B 12.27 B EBIT 2.46 B2.79 B2.87 B3.13 B2.82 B3.13 B 11.95 B Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 79 M83 M80 M87 M76 M79 M 322 M